Liu, Kevin, O'Donnell, Christopher, Flick, Andrew, Ding , Hong, Leverett, Carolyn, Kyne, Robert and Fink, Sarah (2016) Synthetic approaches to the 2014 new drugs. Bioorganic and Medicinal Chemistry, 24 (9). pp. 1937-1980. ISSN 0968-0896; 1464-3391

Abstract

New drugs introduced to the market every year represent privileged structures for particular biological targets. These new chemical entities (NCEs) provide insight into molecular recognition and also serve as leads for designing future new drugs. This annual review covers the synthesis of thirty-seven NCEs that were approved for the first time in 2014 and one drug which was approved in 2013 and was not covered in a previous edition of this review.

Item Type:	Article
Additional Information:	Unmapped bibliographic data: LA - English [Field not mapped to EPrints] ST - Synthetic approaches to the 2014 new drugs [Field not mapped to EPrints] AU - Flick, A. C. [Field not mapped to EPrints] AU - Ding, H. X. [Field not mapped to EPrints] AU - Leverett, C. A. [Field not mapped to EPrints] AU - Kyne, R. E. [Field not mapped to EPrints] AU - Liu, K. K. C. [Field not mapped to EPrints] AU - Fink, S. J. [Field not mapped to EPrints] AU - O'Donnell, C. J. [Field not mapped to EPrints] AD - (Flick, Leverett, O'Donnell) Pfizer Worldwide Research and Development, Groton Laboratories, 445 Eastern Point Road, Groton, CT 06340, United States [Field not mapped to EPrints] M3 - Review [Field not mapped to EPrints] DB - Embase [Field not mapped to EPrints] DP - Ovid Technologies [Field not mapped to EPrints] AN - 20160275380 [Field not mapped to EPrints]
Keywords:	Medicine
Date Deposited:	16 Nov 2016 00:45
Last Modified:	16 Nov 2016 00:45
URI:	https://oak.novartis.com/id/eprint/28514